Literature DB >> 32851580

Addressing free fatty acid receptor 1 (FFAR1) activation using supervised molecular dynamics.

Silvia Atanasio1, Giuseppe Deganutti2,3, Christopher A Reynolds1,4.   

Abstract

The free fatty acid receptor 1 (FFAR1, formerly GPR40), is a potential G protein-coupled receptor (GPCR) target for the treatment of type 2 diabetes mellitus (T2DM), as it enhances glucose-dependent insulin secretion upon activation by endogenous long-chain free fatty acids. The presence of two allosterically communicating binding sites and the lack of the conserved GPCR structural motifs challenge the general knowledge of its activation mechanism. To date, four X-ray crystal structures are available for computer-aided drug design. In this study, we employed molecular dynamics (MD) and supervised molecular dynamics (SuMD) to deliver insights into the (un)binding mechanism of the agonist MK-8666, and the allosteric communications between the two experimentally determined FFAR1 binding sites. We found that FFAR1 extracellular loop 2 (ECL2) mediates the binding of the partial agonist MK-8666. Moreover, simulations showed that the agonists MK-8666 and AP8 are reciprocally stabilized and that AP8 influences MK-8666 unbinding from FFAR1.

Entities:  

Keywords:  FFAR1; G protein-coupled receptors (GPCRs); GPR40; MD; Molecular dynamics; SuMD; Supervised molecular dynamics

Year:  2020        PMID: 32851580     DOI: 10.1007/s10822-020-00338-6

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  3 in total

1.  Intermolecular Interactions in G Protein-Coupled Receptor Allosteric Sites at the Membrane Interface from Molecular Dynamics Simulations and Quantum Chemical Calculations.

Authors:  Tianyi Ding; Dmitry S Karlov; Almudena Pino-Angeles; Irina G Tikhonova
Journal:  J Chem Inf Model       Date:  2022-09-30       Impact factor: 6.162

2.  Deciphering the Agonist Binding Mechanism to the Adenosine A1 Receptor.

Authors:  Giuseppe Deganutti; Kerry Barkan; Barbara Preti; Michele Leuenberger; Mark Wall; Bruno G Frenguelli; Martin Lochner; Graham Ladds; Christopher A Reynolds
Journal:  ACS Pharmacol Transl Sci       Date:  2021-01-21

3.  Supervised molecular dynamics for exploring the druggability of the SARS-CoV-2 spike protein.

Authors:  Giuseppe Deganutti; Filippo Prischi; Christopher A Reynolds
Journal:  J Comput Aided Mol Des       Date:  2020-10-26       Impact factor: 3.686

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.